Novels

New non-coding RNAs regulate blood vessel formation

Researchers at the University of Eastern Finland have discovered previously unknown non-coding RNAs (ncRNAs) involved in the regulation of gene expression of vascular endothelial growth factors (VEGF), the main regulators of angiogenesis. The study, led by the research groups of Associate Professor Minna Kaikkonen-Määttä and Academy Professor Seppo Ylä-Herttuala, provides …

Read More »

Aptorum Group enters into an agreement with Exeltis to develop Aptorum’s new preclinical candidate targeting gynecological conditions in women

NEW YORK & LONDON & PARIS – (BUSINESS WIRE) – Regulatory news: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) (“Aptorum Group” or “Aptorum”), a clinical-stage biopharmaceutical company, has entered into an agreement with Exeltis (“Exeltis”) (a division of the global pharmaceutical group Insud Pharma) to develop, manufacture and market …

Read More »

New pipeline identifies millions of molecular targets in SARS-CoV-2

Researchers in the United States have developed a new pipeline for high-throughput automated annotation of genes, proteins and functional domains in the genome of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent responsible for the 2019 coronavirus disease (COVID-19). The team at IBM Almaden Research Center in San …

Read More »

New coronavirus in Nevada: live blog

New coronavirus in Nevada: Wednesday, May 5, 2021 6:22 pm | May 5, 2021 Pandemic Creates Barriers to Getting Cancer ScreeningsBy Isaac Hoops / Natalie Van Hoozer Amid the COVID-19 pandemic, routine cancer screenings have declined nationwide. Health officials are encouraging Nevadans to talk to their providers about when it …

Read More »

New drug offers quick relief from restlessness in severe mental illness

An experimental orally dissolving film formulation of dexmedetomidine (BXCL501, BioXcel Therapeutics) may provide rapid relief from acute agitation associated with schizophrenia or bipolar disorder (TB), according to the results of two phase 3, randomized and controlled trials. placebo-controlled. Dr Leslie Citrome For both disorders, BXCL501 showed “superiority over placebo” by …

Read More »